Friday, February 06, 2004

Cuba: Joint ventures

"CHINA is interested in introducing techniques developed on the island into its public health system. In that context, the joint enterprise Biotech Pharmaceutical is to manufacture and market in that nation the H-R3 humanized monoclonal antibody – created by researchers at the island’s Molecular Immunology Center (CIM) – for the treatment of brain and neck tumors."

Interesting info with lots of spin.

0 Comments:

Post a Comment

<< Home